MOACM
IMUX icon

Mutual of America Capital Management’s Immunic IMUX Stock Holding History

Mutual of America Capital Management’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-3
Closed -$29K – 1254
2015
Q1 		$29K Buy
+3
New +$27.6K ﹤0.01% 1224

Other funds holding IMUX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Mutual of America Capital Management's IMUX Position: Q2 2015 in Review

Mutual of America Capital Management sold out of Immunic (IMUX) in Q2 2015, closing a stake of 3 shares — an estimated $29K sold.

Mutual of America Capital Management first reported a position in IMUX in Q1 2015 and held it in 1 quarter. The position peaked at $29K in Q1 2015. 52 funds tracked by Wall St. Rank hold IMUX as of Q2 2015.

  • Mutual of America Capital Management reported no remaining Immunic position as of Q2 2015 after selling out during the quarter.
  • Mutual of America Capital Management sold 3 Immunic shares in Q2 2015, an estimated $29K.
  • Mutual of America Capital Management first reported a position in Immunic in Q1 2015 and held it in 1 quarter.
  • Mutual of America Capital Management's Immunic position peaked at $29K in Q1 2015.
  • 52 funds tracked by Wall St. Rank held Immunic as of Q2 2015.

Based on Mutual of America Capital Management's 13F filing for Q2 2015, filed 5 Aug 2015.